INS and type 2 diabetes mellitus: The current study showed that patients with T2D managed with basal–bolus insulin regimens use up to a mean of 2.16 TS/patient/day, followed by premixed insulin (1.65 TS/patient/day), and basal insulin (1.16 TS/patient/day).